PMC:7784834 / 549-832
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"16","span":{"begin":162,"end":167},"obj":"Gene"}],"attributes":[{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"Gene:43740568"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" approaches using FDA approved drugs can expedite the drug discovery process by providing leads that can be pursued. In this report, two drug targets, namely the spike protein and main protease, belonging to structural and non-structural class of proteins respectively, were utilized"}